S. S. Lee

Sung Sook Lee, F. Shepherd, Dong-Wan Kim, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer

Sung Sook Lee, H. Chang, Yoon-Koo Kang, 2008, Cancer Chemotherapy and Pharmacology.

Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study.

Sung Sook Lee, Tae Won Kim, H. Chang, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival

Dae-Ho Lee, J. Huh, C. Suh, 2007, Annals of Hematology.

BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin’s lymphoma patients: comparative analysis of efficacy and toxicity

Sung Sook Lee, J. Huh, C. Suh, 2007, Annals of Hematology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer

Sung Sook Lee, H. Chang, Yoon-Koo Kang, 2010, Cancer Chemotherapy and Pharmacology.

The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites

H. Chung, S. Noh, S. Rha, 2010, Journal of Cancer Research and Clinical Oncology.

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung Cancer

You Won Lee, Sung Sook Lee, A. Drilon, 2020, Clinical Cancer Research.

Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety

Jinny Park, Kihyun Kim, D. S. Lee, 2010, Annals of Hematology.

Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.

Tae Won Kim, H. Chang, Yoon-Koo Kang, 2007, Japanese journal of clinical oncology.

Brain metastases in breast cancer: prognostic factors and management

Sung Sook Lee, Sung-Bae Kim, S. Ahn, 2008, Breast Cancer Research and Treatment.

Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis.

Sung Sook Lee, Tae Won Kim, H. Chang, 2007, Japanese journal of clinical oncology.

Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma

Sung Sook Lee, Dae-Ho Lee, C. Kim, 2010, Investigational new drugs.

Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma

Sang-We Kim, Dae-Ho Lee, C. Suh, 2011, Investigational New Drugs.

Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma

Tae Won Kim, Myung-Hwan Kim, D. Park, 2012, Acta oncologica.

Monoclonal Proteinuria as a Prognostic Factor for Multiple Myeloma Patients with Intact Immunoglobulin Type

Sung Sook Lee, Seong-Ho Choi, S. Sym, 2007 .

A Case of Leukemic Pleural Infiltration in Atypical Chronic Myeloid Leukemia

Tae Won Kim, H. Chang, Yoon-Koo Kang, 2006, Journal of Korean medical science.

The Role of An Early Interim 18 F-FDG PET/CT for Prediction of Outcomes of Patients with Peripheral T Cell Lymphoma

Hyun Soo Hong, Dae-Ho Lee, C. Kim, 2008 .

Both-sided intra-atrial intracardiac metastases as the initial presentation of testicular seminoma.

Sung Sook Lee, Yoon-Koo Kang, Sang-We Kim, 2007, Japanese journal of clinical oncology.

Prognosis of pN3 stage gastric cancer.

H. Chung, W. Hyung, S. Noh, 2009, Cancer research and treatment : official journal of Korean Cancer Association.

Salvage Chemotherapy With Biweekly Irinotecan, Plus 5-Fluorouracil and Leucovorin in Patients With Advanced Gastric Cancer Previously Treated With Fluoropyrimidine, Platinum, and Taxane

Sung Sook Lee, Tae Won Kim, H. Chang, 2008, American journal of clinical oncology.

Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea

Sung-Bae Kim, S. Ahn, S. Ahn, 2011, Breast Cancer Research and Treatment.

Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer

Yoon-Koo Kang, Kab-Choong Kim, J. Yook, 2012, Cancer Chemotherapy and Pharmacology.

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer

Sung Sook Lee, Tae Won Kim, H. Chang, 2010, Cancer Chemotherapy and Pharmacology.

A case of primary squamous cell carcinoma of the pancreas responding to gemcitabine, capecitabine, and cisplatin chemotherapy

Dongho Kim, Jae-Lyun Lee, S. Noh, 2009 .

Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial

R. Plummer, B. Melichar, Yoon-Koo Kang, 2019, Journal of Immunotherapy for Cancer.

Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer

Dong-Wan Kim, D. Heo, B. Keam, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced gastric or gastroesophageal junction cancer from JAVELIN solid tumor phase Ib trial: Analysis of safety and clinical activity.

Sung Sook Lee, B. Melichar, Yoon-Koo Kang, 2016 .

Abstract CT111: Avelumab (anti-PD-L1) as first-line maintenance (1L mn) or second-line (2L) therapy in patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): updated phase Ib results from the JAVELIN Solid Tumor trial

R. Plummer, B. Melichar, Yoon-Koo Kang, 2018, Clinical Trials.

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

You Won Lee, S. Heo, S. Lim, 2021, Clinical & translational immunology.

A Phase II Study of Clinical Outcomes of 3-Week Cycles of Irinotecan and S-1 in Patients with Previously Untreated Metastatic Colorectal Cancer: Influence of the UGT1A1 and CYP2A6 Polymorphisms on Clinical Activity

Sung Sook Lee, Tae Won Kim, H. Chang, 2012, Oncology.

A Phase 1/2 Study of Lazertinib 240 mg in Patients with Advanced EGFR T790M-Positive Non-Small Cell Lung Cancer After Prior EGFR Tyrosine Kinase Inhibitors.

J. Ahn, M. Ahn, E. Cho, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Intramedullary spinal cord metastases: a single-institution experience

Sung-Bae Kim, Jin-Hee Ahn, S. Sym, 2007, Journal of Neuro-Oncology.

Comparison of Prognostic Genomic Predictors in Colorectal Cancer

Ju-Seog Lee, I. Chu, S. Kopetz, 2013, PloS one.

A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction

Sung Sook Lee, Tae Won Kim, H. Chang, 2011, Investigational New Drugs.

Lazertinib versus Gefitinib as First-line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.

M. Ahn, E. Cho, Dong-Wan Kim, 2023, Cancer research and treatment.

MA26.09 Lazertinib, a Third Generation EGFR-TKI, in Patients with EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/II Study

Dohoung Kim, Y. Min, S. Shin, 2018, Journal of Thoracic Oncology.

Population Pharmacokinetic Analysis of Meropenem After Intravenous Infusion in Korean Patients With Acute Infections.

Jae-Gook Shin, Y. Kim, K. Jin, 2018, Clinical therapeutics.

Efficacy and Safety of S-1 Monotherapy in Patients with Advanced Biliary Tract Adenocarcinoma

Sung Sook Lee, H. Chang, Myung-Hwan Kim, 2009, Oncology.

Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.

Sung Sook Lee, Kyung-Ja Cho, Sung-Bae Kim, 2007, Japanese journal of clinical oncology.

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

D. Park, D. Seo, D. Han, 2009, British Journal of Cancer.

Clinicopathological review of 61 patients with early bile duct cancer.

J. Cha, Myung-Hwan Kim, Sang‐Gon Lee, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer

Sung Sook Lee, H. Chung, W. Hyung, 2012, Investigational New Drugs.

A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer: A Prospective, Multicenter Trial of the Korean Cancer Study Group

Sung Sook Lee, Tae Won Kim, Tae-You Kim, 2014, American journal of clinical oncology.

YH25448, a 3rd generation EGFR-TKI, in patients with EGFR-TKI-resistant NSCLC: Phase I/II study results.

J. Ahn, M. Ahn, E. Cho, 2018 .

A Phase II Study of Cetuximab (Erbitux®) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer

Sung Sook Lee, Tae Won Kim, H. Chang, 2007, Journal of Korean medical science.

Dose escalation of imatinib after failure of standard dose in Korean patients with metastatic or unresectable gastrointestinal stromal tumor.

Tae Won Kim, H. Chang, Yoon-Koo Kang, 2008, Japanese journal of clinical oncology.

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer

D. Park, D. Seo, Jung-shin Lee, 2009, British Journal of Cancer.

The effect of Epstein–Barr virus status on clinical outcome in Hodgkin’s lymphoma

H. Koo, Y. Ko, B. Ryoo, 2006, Annals of Hematology.

Prognosis of pN3 stage gastric cancer.

H. Chung, W. Hyung, S. Noh, 2009, Cancer research and treatment : official journal of Korean Cancer Association.

Multicenter Phase II Trial of 90Y-Ibritumomab Tiuxetan with High-Dose Chemotherapy (Busulfan/Cyclophosphamide/Etoposide) Followed by Autologous Stem Cell Transplantation in Relapsed, Refractoried, or High-Risk B-Cell NHL.

C. Suh, W. Kim, J. Jo, 2007 .

A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)

J. W. Kim, B. Nam, S. Koh, 2023, Cancer research and treatment.

A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer

Sung Sook Lee, Tae Won Kim, H. Chang, 2011, Cancer Chemotherapy and Pharmacology.

Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: A retrospective analysis

H. Chang, Yoon-Koo Kang, S. Sym, 2008, Journal of gastroenterology and hepatology.